No abstract available
MeSH terms
-
Anticoagulation Reversal* / adverse effects
-
Anticoagulation Reversal* / methods
-
Cerebral Hemorrhage* / chemically induced
-
Cerebral Hemorrhage* / drug therapy
-
Clinical Trials, Phase IV as Topic
-
Factor Xa Inhibitors* / adverse effects
-
Factor Xa* / administration & dosage
-
Factor Xa* / adverse effects
-
Humans
-
Multicenter Studies as Topic
-
Randomized Controlled Trials as Topic
-
Recombinant Proteins* / administration & dosage
-
Recombinant Proteins* / adverse effects
-
Research Design
-
Rivaroxaban / adverse effects
Substances
-
Factor Xa
-
Factor Xa Inhibitors
-
PRT064445
-
Recombinant Proteins
-
Rivaroxaban